2018 American Transplant Congress Archives - Page 211 of 211

T Cell Exhaustion Contributes to Operational Tolerance of Liver Allografts in Pediatric Liver Transplant Recipients

B. Ramaswami,¹ M. Marrari,² O. Yoshida,⁵ X. Guo,³ W. Hoffman,³ C. Bentlejewski,² D. Metes,¹ A. Demetris,^1,2 A. Zeevi,² A. Thomson,¹ G. Mazariegos,⁴ G. Chalasani.^1,3
T Cell Exhaustion in Kidney Transplant Patients

M. Fribourg,¹ C. Fischman,² L. Anderson,² B. Burrell,³ P. Heeger,² P. Cravedi.²
T Cell Immunomonitoring Including Donor Specific Treg Expansion Prospectively Predicts Renal Allograft Tolerance Induced by Transient Mixed Chimerism

K. Hotta, T. Oura, A. Dehnadi, K. Huh, M. Matsunami, H. Sasaki, G. Benichou, J. Madsen, A. Cosimi, T. Kawai.
T Cell Lineage Imbalance and Regulatory Immune Populations in HCC Patients Undergoing Downstaging While Waitlisted for Liver Transplantation

P. Thevenot,¹ K. Nunez,¹ T. Sandow,² J. Gimenez,² J. Gonzalez-Rosario,¹ M. Patel,¹ A. Alfadhli,¹ D. Wyczechowska,³ A. Cohen.¹
T cell Phenotypes Predict Infectious Risk in Transplanted Children

E. T. Chambers,¹ R. Ettenger,² H.-J. Lee,¹ C. Chan,¹ L. Stempora,¹ B. Warshaw,³ P. Grimm,⁴ E. F. Reed,² M. Sarwal,⁵ A. Kirk.¹
T Cell-Mediated Rejection Poses Greater Risk to Graft Survival Than Antibody-Mediated Rejection in Heart Transplants

M. Parkes, K. Famulski, P. Halloran, The INTERHEART Study Group.
T-bet and STAT6 Double Deficiency Favors IL-17 Immunity after Lung Transplantation

F. Liang,¹ R. Chen,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
T-Cell Depletion Does Not Increase the Risk of CMV Infection in Donor-Positive, Recipient-Negative Kidney Transplants Due to the Absence of Preformed CMV-Specific Cell-Mediated Immunity

M. Jarque,¹ H. Kaminski,² L. Couzi,² E. Crespo,¹ J. Déchanet-Merville,³ S. Luque,¹ N. Montero,⁴ M. Pascual,⁵ O. Manuel,^5,6 P. Merville,² O. Bestard.^1,4
T-Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell Generation and Regulatory-T-Cell-Dependent Cardiac Allograft Survival

N. Chun,¹ D. Verghese,¹ M. Demir,¹ M. Fribourg,³ I. Llaudo,¹ E. Medof,⁴ P. Heeger.¹
T2Candida for Diagnosis of Candidemia in Solid Organ Transplant Recipients

T. McCarty, J. Baddley, J. Locke, R. Mannon, D. Eckhoff, V. Rusanov, S. Moser, P. Pappas.
TACI Polymorphisms Associated with Allograft Rejection in Mice and in Man

M. Barbosa,¹ E. Farkash,² J. Platt,³ M. Cascalho.³
TACI-Ig as a Desensitization Agent in a Rat Model of Antibody Mediated Rejection

N. Wilson,¹ B. Verhoven,² B. Boldt,² N. Bath,² X. Ding,¹ R. Redfield III.²
Tacrolimus and Isavuconazole Therapy: What about the Drug Interaction?

C. Gill,¹ N. Mercuro,¹ R. Kenney,¹ A. Jantz,¹ B. Summers,¹ N. Sulejmani,¹ S. Davis.^1,2
Tacrolimus Exposure in Human Proximal Tubule Cells Results in Differentially Increased CTGF Expression in Relation to Pharmacogenetic Variants of CYP3A5 and ABCB1

N. Knops,¹ Y. Ramazani,² B. Van den Heuvel,² R. Goldschmeding,³ T. Nguyen,³ E. Levtchenko,¹ D. Kuypers.⁴
Tacrolimus Metabolism in Subjects with Potentially Absent CYP3A Activity

A. Scheibner,¹ R. Remmel,² D. Schladt,³ W. Oetting,¹ W. Guan,⁴ B. Wu,⁴ C. Door,⁵ A. Israni,⁵ P. Jacobson.¹
Tacrolimus Pharmacokinetics (PK) at Low, Medium, and High Trough Levels in Patients Converted from Twice-Daily Immediate-Release Tacrolimus (TacBID) to Once-Daily Extended-Release Tacrolimus (LCPT)

P. Malvezzi,¹ S. Bunnapradist,² D. Stevens,³ M. Moten,³ A. Loh,³ S. Patel,³ L. Rostaing.¹
Tacrolimus-Based Maintenance Immunosuppression Decreases the Number of Peripheral Blood Transitional B Cells in Nonhuman Primates

J. Paster, K. Pruner, M. Hanekamp, J. O., W. Sommer, K. Robins, A. Bean, G. Benichou, J. Madsen.
Taking Specific Steps to Pursue Living Donor Kidney Transplant is Associated with Greater Odds of Having a Potential Living Donor Identified

A. Ali,¹ D. Toews,¹ N. Singh,¹ A. Ayub,¹ C. Richardson,¹ S. Dano,¹ D. Wong,¹ J. Peipert,² A. Waterman,² M. Novak,¹ I. Mucsi.¹
Taking Your Center's Temperature: Using a Heat Map to Target Your Transplant-Specific Education for Regulatory Compliance

J. Anderson, D. Cassidy, D. Dubay, P. Hart, A. Hauser, N. Pilch.
Target Tacrolimus Troughs and CYP3A5 Polymorphisms Do Not Predict Therapeutic Drug Exposure in African American and Caucasian Renal Transplant Recipients

K. Tornatore,^1,4 K. Attwood,² D. Brazeau,³ S. Chang,⁴ R. Venuto.⁴
Targeted Donor Complement Blockade after Brain-Death Prevents Delayed Graft Function but Not Progression to Antibody-Mediated Rejection in a Non-Human Primate Model of Kidney Allo-Transplantation

J. Danobeitia,¹ T. Zens,¹ L. Zitur,¹ P. Chlebeck,¹ J. Torrealba,³ D. Burguete, E. Van Amersfoort,² A. Relan,² A. D'Alessandro,¹ L. Fernandez.¹
Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation

J. Kwun,¹ B. Ezekian,¹ M. Manook,¹ J. Park,¹ J. Yoon,¹ J. Sloan-Lancaster,² C. Fortier,³ P. Rao,⁴ S. Knechtle.¹
Targeting Histone Deacetylase in Renal Tubular Epithelial Cells Inhibits Amplification of TH1 Cell-Mediated Inflammation

S. Kang, Y. Kim, S. Seo.
Targeting LTβR Classical NFκB Signaling Facilitates Inflammation Resolution

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
Targeting Lymphotoxin Signaling in Lymphatics Regulates Immune Sensitization, Elicitation, and Resolution

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
Targeting Plasma Cells with Anti-CD38mAb (Daratumumab) and CXCR4 Antagonist (Plerixafor) for Desensitization

J. Kwun,¹ E. Brian,¹ M. Manook,¹ J. Park,¹ K. Freischlag,¹ J. Yoon,¹ J. Yi,¹ M. Stegall,² S. Knechtle.¹
Tax1bp3 is Upregulated in the Ischemia/Reperfusion Injury of Kidney

W. Qiu, J. Lin, Y. Tian.
Technical Aspects of Orthotopic Liver Transplantation – A Survey-Based Study within the Eurotransplant, Swisstransplant, Scandiatransplant and British Transplantation Society Networks

Z. Czigany,¹ J. Bednarsch,¹ J. Böcker,¹ F. Meister,¹ I. Amygdalos,¹ W. Schöning,¹ T. Ulmer,¹ X. Rogiers,² P. Dutkowski,³ P-.D. Line,⁴ M. Malagó,⁵ U. Neumann,¹ G. Lurje.¹
Technical Challenges in Living Donor Kidney Transplantation – Diagnosis and Solutions

R. Öllinger,¹ K. Alqasim,¹ F. Klein,¹ N. Raschzok,¹ P. Ritschl,¹ S. Chopra,¹ N. Otto,² T. Denecke,³ U. Gerlach,¹ M. Schmelzle,¹ P. Reinke,² J. Pratschke.¹
Telehealth Evaluations to Screen Kidney Transplant Candidates Does Not Adversely Affect Time to or Rate of Transplant

R. Forbes,^1,2 D. Rybacki,¹ T. Johnson,¹ D. Shaffer,^1,2 D. Hale.^1,2
Telemedicine Implementation in Organ Transplantation at a Metropolitan Academic Medical Center

D. Tsapepas, H. Li, D. Kohlberg, B. Watts, J. Monteiro, A. Monteiro, N. Jandovitz.
Temporal and Geographical Trends of Intestinal Transplantation in the USA

M. Segovia,¹ S. Jafri,³ B. Summers,³ T. Schiano,² T. Pietrowsky,³ A. Al-Osaimi,⁵ A. Mavis,¹ S. Horslen.⁴
Temporal Changes in Impact of HLA Mismatch among Pediatric Kidney Transplant Recipients

J. Ruck, A. Massie, N. Desai, D. Segev, J. Garonzik-Wang.
Temporal Changes in the Characteristics and Sensitization of Kidney Paired Donation Registrants

C. Holscher,¹ K. Jackson,¹ A. Thomas,¹ C. Haugen,¹ S. DiBrito,¹ M. Ronin,² A. Waterman,^3,4 A. Massie,^1,5 J. Garonzik Wang,¹ D. Segev.^1,5
Temporal Trends in Living Kidney Donor Candidates

S. Singh,^1,2 V. DiCecco,² M. Luo,² Y. Li,² O. Famure.²
Temporal Trends, Predictive Factors, and Regional Differences in Discard of Increased-Risk Kidneys

J. Lipinska, D. Clark, J. Whiting.
Temporal Variability of IgG Subclasses

D. Pinelli, M. Gopalakrishnan, A. Joong, P. Thrush, A. Tambur.
Temporary Contraindication of Obese Recipients in Kidney Transplantation: A New Morphometric Tool for Decision Support

U. Pinar,¹ Y. Renard,² D. Bedretdinova,³ C. Lebacle,¹ B. Parier,¹ Y. Hamoudi,¹ J. Irani,¹ T. Bessede.¹
Ten Year Follow-Up of Islet Recipients on Anti-LFA1 Therapy: Over-Immunosuppression Leads to Operational Tolerance?

J. Gardner,¹ A. Posselt,¹ S. Wisel,¹ U. Mashirani,² G. Szot,¹ V. Nguyen,¹ K. Johnson,¹ J. McElroy,¹ Q. Tang,¹ P. Stock.¹
Ten Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients

S. El Hajj, J. Azzi, M. Kim, S. Gabardi.
TGF-b Plus Rapamycin Induce Foxp3 and Promote iTreg Development and Suppressive Function, Leading to Long-Term Allograft Survival

L. Wang, A. Samanta, R. Han, N. Zhou, W. Hancock.
TGR5-Mediated AMPK/mTOR Signaling Regulates Macrophage Migration and Polarization in Liver Ischemia Reperfusion

S. Zhou, H. Zhou, R. Liu, F. Zhang, X. Wang, L. Lu.
Th17 and NK Responses Are Differentially Induced in Renal Allografts According to Recipient Murine Cytomegalovirus Dose and Strain

M. Shimamura,¹ M. Li,² S. Boddeda,¹ B. Chen,² Q. Zeng,¹ T. Schoeb,² V. Velazquez.¹
The Advantage of Utilizing ABO and HLA Compatible Pairs in Kidney Paired Donation

A. Basu,¹ C. Kosberg,¹ H. Khamash,² M. Mai,³ M. Prieto,¹ C. Schinstock.¹
The Aggressive Phenotype: Center-Level Characteristics in the Use of Suboptimal Lungs

M. Kosztowski, E. Bush, X. Luo, A. Thomas, M. Bowring, D. Segev, J. Garonzik Wang.
The AKI-Predict-Score: A New Prediction Model for Acute Kidney Injury after Liver Transplantation

M. Kalisvaart,¹ A. Schlegel,¹ I. Umbro,² K. Roberts,¹ D. Mirza,¹ T. Perera,¹ J. Isaac,¹ A. P. Mitterhofer,² J. de Jonge,³ P. Muiesan.¹
The Altruistic Living Kidney Donor Phenotype – From Inquiry to Donation

V. Kumar, P. MacLennan, M. Bonventre, M. Hanaway, R. Reed, J. Locke.
The Anterior Rectus Sheath Approach Resulted in No Difference in Wound Complication Rates in Obese versus Non-Obese Renal Transplant Recipients

S. King,² S. Hill,² L. Lipscomb,² A. Jones,² R. Jeffries,² J. Africa.¹
The Association between Transplant Glomerulopathy and Graft Outcomes among Patients Undergoing Kidney Transplantation: Results of a Meta-Analysis

G. Kovács,¹ G. Devercelli,² Z. Vokó,^1,3 T. Zelei,¹ I. Hirji,² P. Keown.^4,5
The ATHENA Study: 12 Months Safety and Efficacy Data from Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in De Novo Kidney Transplant Patients

B. Suwelack,¹ C. Sommerer,¹ D. Dragun,¹ O. Witzke,¹ C. Hugo,¹ N. Kamar,² P. Merville,² A. Hauser,¹ P. Schenker,¹ M. Junge,³ B. Nashan,¹ F. Thaiss.¹
The Benefit of Higher KDPI Renal Transplantation over Waiting for a Better Offer

E. Grodstein,¹ J. Yang,² V. Nair,¹ E. Molmenti,¹ L. Teperman.¹
The BEST Trial: A Prospective Randomized Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression

E. Woodle,¹ D. Kaufman,² A. Shields,¹ J. Leone,³ A. Wiseman,⁴ A. Matas,⁵ P. West-Thielke,⁶ E. King,¹ R. Alloway.¹
The Brazilian Epitope Virtual Crossmatch Protocol: A Reliable Tool for Increasing Kidney Allocation among Highly Sensitized Patients

L. Sousa,¹ A. Silva,¹ M. Marroquim,¹ A. Coelho,¹ A. Lima,¹ F. Silva,¹ C. Carracosa,² G. Willcox,³ T. Leão,³ B. Correa,³ E. Guimarães,³ G. Maciel,³ J. Andrade,⁴ A. Andrade,⁴ R. Neto,⁴ S. Cavalcante,⁴ C. Leão,⁴ F. Cavalcante,⁵ A. Holanda,⁵ N. Gomes,⁶ A. Rego,⁶ S. Monte.¹
The Chauvet Workgroup: From Inception to the Future

H. Amer,¹ S. Jowsey-Gregoire,¹ M. Kumnig,² E. Moreno,³ W. Dean,⁴ C. Brown,⁵ S. Jarvholm,⁶ K. Coffman,⁷ P. Petruzzo,⁸ E. Morelon.⁸
The Clinical Efficacy of Seasonal Influenza Vaccination – Characteristics of Two Outbreaks of Influenza A(H1N1) in Immunocompromised Patients

I. Helanterä,¹ R. Janes,² V-.J. Anttila.³
The Clinical Significance of Pretransplant C1q Assay Status in Positive Crossmatch Kidney Transplantation

J. Lee,¹ D. Kim,¹ B. Park,² S. Song,³ J. Lee,⁴ Y. Jung,¹ J. Lee,¹ J. Lee,¹ B. Kim,⁵ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
The Combination of Area under Curve of Estimated Glomerular Filtration Rate for 2 Years and Annual Rate Change of Estimated Glomerular Filtration Rate Predicts Long-Term Graft Survival in Kidney Transplants

E. Lee,¹ J. Jeon,¹ S. Kim,¹ M. Kim,¹ K. Lee,¹ H. Jang,¹ J. Lee,¹ J. Hwang,² D. Kim,¹ Y-.G. Kim,¹ H. Oh,¹ W. Huh,¹ J. Kim.³
The Combination of pAMR and Circulating Donor-Specific Antibodies is Even More Associated with Cardiac Allograft Vasculopathy after Heart Transplant

J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Complexity of HLA-DQ

D. Pinelli, A. Tambur.
The Continuous Debate of Older Donors into Older Recipients: Another Angle

J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Cost Savings of Preemptive Kidney Transplantation

P. Dean,¹ H. Heien,² K. Swanson,² B. Borah,² L. Sangaralingham,² J. Naessens,² M. Stegall.¹
The Effect of an Organ Procurement Experience on Preclinical Medical Student Perceptions of Transplant Surgery

M. Feinstein, S. Marcus, D. Amara, B. Durcanova, G. Roll, B. Orandi.
The Effect of Donor Nephrectomy in the Older Living Kidney Donor: Single Centre Experience

K. Koutroutsos, A. Kousios, R. Charif, J. Galliford, N. Stubbs, H. Dulku, H. Orr, M. Loucaidou.
The Effect of Donor-Recipient Gender Matches on Living Donor Liver Transplantation

J. Han, Y. You, H. Choi, B. Kwak, D. Kim.
The Effect of Intravenous Immunoglobulin on In Vitro Human Antibody Binding to Genetically-Engineered Pig Cells – Relevance to Clinical Xenotransplantation –

T. Yamamoto,¹ Q. Li,¹ H. Iwase,¹ D. Ayares,² D. Cooper,¹ H. Hara.¹
The Effect of Perioperative Antiplatelet/Anticoagulant Therapy on the Incidence of Early Postoperative Thromboembolic Complications and Bleeding in Kidney Transplantation – A Dual Center Retrospective Cohort Study of 2000 Kidney Transplant Recipients

T. van den Berg,¹ R. Minnee,² G. Nieuwenhuijs-Moeke,³ S. Bakker,⁴ R. Pol.¹
The Effect of Pre-Transplant Insomnia and Post-Transplant Insomnia on Survival among Solid Organ Recipients

K-.F. Lee,² Y. Tsai,¹ C. Lin,¹ C-.B. Hsieh,^3,5 S. Wu,⁴ T. Chen,⁵ Y-.C. Lin,¹ W-.H. Lee,^6,7 F. Lin,⁸ C. Tsai.^1,9,10
The Effect of Steroid Maintenance in Recipients with Pancreas Transplant Alone: A Single Center Experience

J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.
The Effect of Tacrolimus Trough Level and Intrapatient Variability on the Transplant Outcomes in Kidney Transplantation

J. Lee,¹ J. Lee,¹ Y. Jung,¹ D. Kim,¹ S. Song,² J. Lee,³ J. Lee,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ B. Kim,⁴ K. Huh.¹
The Effects of Age-Adjusted Marriage Duration on Graft Outcomes in Spousal Donor Kidney Transplantation

M. Yu,¹ J. Park,² H. Cho,¹ J. Ha,¹ C. Ahn,¹ Y. Kim,¹ H. Lee.¹
The Effects of Pre-Transplant Pyuria of the Deceased Donor on Post-Transplant Urinary Tract Infections in the Case of Gender Mismatch Transplantation

Y. Kim,¹ S. Park.²
The Efficacy and Safety of Rituximab as Induction Therapy in Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials

X. Wang,¹ J. Chen,² X. Tu,² Y. Qiu,¹ T. Song,¹ T. Lin.¹
The Efficacy of Laser Speckle Flowgraphy Device for Intraoperative Evaluation of Renal Blood Flow after Reperfusion

M. Muramatsu,¹ Y. Itabashi,¹ Y. Takahashi,² K. Sakurabayashi,¹ T. Mizutani,¹ Y. Hyodo,¹ Y. Hamasaki,² T. Kawamura,¹ K. Sakai,¹ S. Shishido.^1,2
The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial

J. Yang, X. He, L. Wu, Z. Guo.
The Ethical Turmoil of Imminent Death Donation

N. Galvan, J. Geha, R. Ackah, M. Kueht, R. Cotton, C. O'Mahony, A. Rana, J. Goss.
The Etiologies and Impact of Hospitalization in Older Kidney Transplant Recipients

M. Posadas Salas, R. Rodriguez, P. Amaechi, V. Rao, D. Taber.
The Fate of Older Candidates Referred for Kidney Transplantation

M. Shwetar, K. Abdel-Kader, B. Concepcion.
The Feasibility of Laparoscopic Living Donor Right Hepatectomy Compared to Open Surgery Including 100 Laparoscopic Cases

J. Rhu, G. Choi, J. Kim, J. Joh, C. Kwon, S. Kim.
The Financial Impact of the Opioid Epidemic on Kidney Transplantation Readmissions

L. Wilson, D. Taber, N. Pilch, R. Gilbert, Z. Elmaasarani, B. O'Brien, N. Patel, P. Mauldin, S. Ball, P. Baliga, J. Fleming.
The First 9 Years of KPD through the National Kidney Registry: Characteristics of Donors and Recipients Compared to National Transplant Registries

S. Flechner,¹ A. Thomas,² M. Ronin,³ J. Veale,⁴ D. Leeser,⁵ S. Kapur,⁶ J. Piepert,⁴ D. Segev,² G. Hil,³ A. Waterman.⁴
The First Series of Ischemia-Free Liver Transplantation in Human

X. He,¹ Z. Guo,¹ S. Huang,¹ Q. Zhao,¹ Y. Tang,¹ Z. Zhang,¹ Z. Zhu,¹ W. Ju,¹ L. Yang,² G. Chen.¹
The Grade of Pre-Transplant Portal Vein Thrombosis in Liver Transplant Recipients Impacts Graft and Patient Survival

M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud, M. Rizzari.
The Impact of a Tobacco Prohibition Policy Compared to a Restrictive Policy on Liver Transplant Candidate Outcomes

A. Likhitsup,¹ A. Hassan,¹ J. Mellinger,¹ F. Askari,¹ G. Winder,² P. Sharma,¹ N. Saeed,³ C. Sonnenday,⁴ R. Fontana.¹
The Impact of ABO Blood Type and Geography on Access to Lung Transplant

W. Tsuang, D. McMichael, X. Wang, M. Budev.
The Impact of Age-Matching on Graft Function and Graft Survival after Living Donor Kidney Transplantation

J. Lee,¹ D. Kim,¹ J. Lee,¹ J. Lee,¹ Y. Jung,¹ M. Ju,¹ S. Song,² J. Lee,³ K. Huh,¹ B. Kim,⁴ S. Kim,¹ Y. Kim,¹ M. Kim.¹
The Impact of Anticoagulation Therapy Modifications during the Index Hospitalization on Clinical Outcomes in Kidney Transplant Recipients

J. Hardcopf, H. Meadows, N. Pilch, C. Perez, N. Patel, J. Fleming, H. Corbo, T. Harrison, B. O'Brien, D. DuBay, P. Baliga, D. Taber.
The Impact of Aorto-Iliac Calcifications on Patient and Graft Survival in Renal Transplant Recipients Using the TASC II Classification

A. Rijkse,¹ M. van der Zijden,² J. Roodnat,² S. Ten Raa,³ D. Bijdevaate,⁴ K. Muller,¹ J. IJzermans,¹ H. Kimenai,¹ R. Minnee.¹
The Impact of Childhood Solid Organ Transplantation on B-Cell Maturation

L. Ionescu,¹ T. Blydt-Hansen,² B. Foster,⁷ S. Mital,³ L. Hamiwka,⁵ U. Allan,³ V. Phan,⁴ P. Birk,⁶ C. Morgan,¹ S. Urschel.¹
The Impact of Conversion from Immediate Release Twice-Daily Tacrolimus (Prograf®) to Once-Daily Extended Release Tacrolimus (Envarsus®) in Liver Transplant Recipients

M. Del Gaudio,¹ M. Cescon,¹ M. Ravaioli,¹ V. Bertuzzo,¹ C. Zanfi,¹ M. Serenari,¹ L. Maroni,¹ C. Morelli,² A. Pinna.¹
The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation

Q. Xu,¹ A. Skaro,² V. McAlister.²
The Impact of Duration on Dialysis on the Pre-Transplant Allosensitization According to Panel Reactive Antibody Levels

Y. Jung,¹ D. Kim,¹ J. Lee,¹ S. Song,² J. Lee,³ B. Kim,⁴ J. Lee,¹ S. Kim,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
The Impact of Early versus Late Clinical Outcomes on Disparities in African-American Kidney Transplant Recipients

D. Taber, J. Fleming, Z. Su, P. Mauldin, J. McGillicuddy, S. Nadig, V. Rohan, P. Baliga, D. Dubay.
The Impact of Immunosuppression on Mineral Metabolism One Year after Kidney Transplantation: Differences between a Mycophenolate-Based Regimen versus an mTOR-Inhibitor-Based One

D. Cucchiari,¹ S. Karam,² P. Ventura-Aguiar,¹ F. Diekmann,¹ J. Torregrosa.¹
The Impact of Induction Agent on Development of Febrile Neutropenia Following Kidney Transplant

G. Dube, S. Husain, D. Cohen, S. Mohan.
The Impact of Lymphocele Formation after Kidney Transplantation on De Novo Donor Specific Antibody Formation

L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, K. Budde, O. Staeck, D. Khadzhynov.
The Impact of Marginal Factors on Postoperative Kidney Function of Complex Living Donors for Kidney Transplantation

T. Hiramitsu, K. Futamura, M. Okada, M. Tsujita, T. Ichimori, N. Goto, S. Narumi, Y. Watarai.
The Impact of Obesity on Incidence of Vascular Complications after Liver Transplantation: A Meta-Analysis

R. Deng, Y. Shi, B. Huang, Y. Ma.
The Impact of Pre-Operative Opioid Use on Delayed Graft Function in Adult Kidney Transplant Recipients

N. Patel, B. O'Brien, D. Taber, N. Pilch, P. Baliga, Z. Elmaasarani, S. Ball, P. Mauldin, L. Wilson, R. Gilbert, J. Fleming.
The Impact of Pre-Transplant Donor Specific Antibodies (DSA) on AMR Rates in HIV-Infected Kidney Transplant Recipients Inducted with IL-2 RA

S. Farouk, B. Rollins, V. Delaney, N. Singh, V. Sehgal, R. Kent, M. Menon, R. Shapiro, S. Florman, G. DeBoccardo.
The Impact of Rapamycin Conversion in Pediatric Liver Transplantation on Anti-HLA Antibody Formation and Allograft Fibrosis

R. Fischer,² L. Fromm,¹ J. Daniel,² A. Kats,² R. Hendrickson,² W. Andrews.²
The Impact of Rituximab Dose on Hepatitis B Virus Reactivation in HBsAg-Negative/anti-HBc-Positive Kidney Transplant Recipients

J. Lee,¹ J. Park,² Y. Jung,¹ D. Kim,¹ J. Lee,¹ S. Song,³ J. Lee,⁴ J. Lee,¹ B. Kim,⁵ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
The Impact of Spontaneous Bacterial Peritonitis on Patient Outcomes after Liver Transplantation Using the Scientific Registry of Transplant Recipient (SRTR) Database

D. Moonka,¹ G. Divine,² S. Nagai.³
The Impact of the Influenza Vaccine on Pediatric Kidney Transplant Outcomes

M. Camerino,¹ S. Jackson,² S. Chinnakotla,³ P. Verghese.¹
The Implications of Impaired Glucose Tolerance after Kidney Transplantation

F. Tinney, Jr.,¹ S. Norman,² A. Naik,² D. Cibrik,² R. Sung,² D. Frietze,³ M. Stegall,⁴ M. Samaniego,² C. Jay.³
The Importance of Transplant Program Measures: Surveys of 3 National Patient Advocacy Groups

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ J. Snyder,^2,5 B. Kasiske,^1,4 A. Israni.^1,2,4
The Incidence and Outcome of Isolated Distal Deep Vein Thrombosis in Kidney Transplant Recipient

M. Kim, J. Hwang, S. Kim, S. Park, I. Moon, J. Kim.
The Incidence and Risk Factors for Non – Adherence to Medical Treatment among Patients after Kidney Transplantation

T. Mashraki,^1,2,3 B. Rozen-Zvi,^1,4 E. Mor,^2,4 A. Yussim,^1,2 C. Avry,^1,4 R. Rahamimov.^1,2,3
The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration

A. Kraljevic, C. D'Agostino, C. Kane, K. Cunningham, A. Shetty, C. Richardson.
The Influence Factors of DCD Donors' Family Members' Willingness in Chinese Current Status (Hunan Province Experience)

B. Tu, C. Li, C. Li, S. Liu, Y. Zhao, X. She, Y. Ming.
The Influence of a Conversion to Sirolimus-Based Immunosuppression on Non-Melanomatous Skin Cancer Incidence in Kidney Transplant Recipients over Long Term Follow Up

F. Daly,¹ P. O'Kelly,¹ F. Moloney,² D. Sexton,¹ P. Conlon.¹
The Influence of Rabbit Antithymocyte Globulin (rATG) Dose on the Incidence of CMV Infection in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis. A Propensity Score Matched Cohort Analysis

M. Ivani de Paula,^1,2 S. Bae,¹ J. Garonzik-Wang,¹ C. Felipe,² M. Cristelli,² A. Massie,^1,3 J. Medina-Pestana,² D. Segev,^1,3 H. Tedesco Silva J�nior.²
The Infusion with a Difference: Patient Experiences with Belatacept

H. Murad, D. Malhotra, E. Cohen, W. Asch.
The Inhibitory Effect of Plasma on Activation of Lymphocytes from Kidney Transplants is Significantly More Severe in Tacrolimus Based Regimen: What Implications for Plasma Exchange Role in Anti-Rejection Therapy?

A. Assounga,^1,2 S. Omarjee.¹
The Initial Hepatic Artery Reperfusion versus Initial Portal Reperfusion in Liver Transplantation: Where Do We Stand?

R. Shahbazov,¹ F. Azari,³ J. Alejo,² M. Talanian,² M. Fox,² K. Kennedy,² S. Kessel,² A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹
The Internet as a Source of Transplant-Related Information for New Kidney Transplant Candidates

W. Fu, N. Chai, P. Yoo.
The Kidney Allocation System from the Perspective of a Small Program in a Donor Service Area

K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² S. Hanna,² J. Africa.¹
The Learning Curve in 100 Consecutive Live Liver Donors Undergoing Pure Laparoscopic Right Hepatectomy

K. Suh, S. Hong, K. Yoon, J-.M. Lee, J-.H. Cho, N-.J. Yi, K. Lee.
The Likelihood of Re-Transplantation in Patients Undergoing Allograft Nephrectomy

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹
The Living Donor Lost Wages Trial: Study Rationale, Protocol, and Update

J. Rodrigue,¹ M. Pavlakis,¹ A. Evenson,¹ A. Fleishman,¹ M. Carroll,¹ D. Mandelbrot,² P. Baliga,³ D. Howard,⁴ J. Schold.⁵
The LncRNA MALAT1 Induces Tolerogenic DCs and Antigen Specific Tregs Subsequently Mediating Cardiac Allograft Tolerance in Mice via MiR-155/DC-SIGN/IL10 Axis

M. Zhang,^1,2 J. Wu,^1,2 H. Zhang,^1,2 M. Liu,^1,2 Y. Zheng,^1,2 X. Jin,^1,2 S. Li,^1,2 Q. Zhao,^1,2 X. Liu,^1,2 Y. Sun,^1,2 B. Yu.^1,2
The Mark of Zorro: IL35-Coated Exosomes Cross-Dress and Exhaust Recipient T & B Cells during Transplant Tolerance

W. Burlingham,¹ J. Sullivan,¹ D. Lema,¹ Y. Tomita,² Y. Zhou,¹ D. Vignali.³
The MicroRNA Landscape of EBV+ and EBV- PTLD

Y. Balachandran,¹ H. Zimmermann,² C. Esquivel,¹ S. Krams,¹ R. Trappe,² O. Martinez.¹
The Net State of Immunosuppression in Septuagenarian Liver Transplant Recipients: Balancing Rejection and Infection Risks

J. Casale,¹ J. Clark,¹ B. Ravichandran,¹ J. LaMattina.²
The Neutrophil to Lymphocyte Ratio is Confounded by MELD in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation

J. McVey, K. Sasaki, F. Dan, Q. Cristiano, H. Koji, M. Charles, A. Federico.
The New Crescentic Incision: A Good Option for Donor Nephrectomy

M. Haberal,¹ M. Kirnap,¹ A. Akdur,¹ E. Ayvazoglu Soy,¹ S. Yildirim,¹ G. Moray,¹ Z. Kayhan,² A. Torgay.²
The Novel Polymer Pro-Drug APP-103 Reduces I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model

K. Minami,^1,3 H. Uehara,^1,3 A. Elkhal,^1,3 A. Weins,³ S. Bae,^2,3 J. Reder,⁴ B. Houser,⁴ P. Kang,^2,3 S. Tullius.^1,3
The Opioid Strikes Back: Pre-Transplant Opioid Exposure is Associated with Increased Readmissions after Renal Transplant

B. O'Brien, N. Patel, L. Wilson, P. Mauldin, S. Ball, R. Gilbert, Z. Elmaasarani, P. Baliga, N. Pilch, D. Taber, J. Fleming.
The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis

R. Deng, B. Huang, Y. Shi, Y. Ma.
The Overriding Importance of HLA-DR Donor-Specific Antibody That is Correlated to CAV after Heart Transplant

E. Kransdorf, J. Patel, M. Kittleson, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Preclinical Application of the Tactile Discrimination Task in Rat Models

S-.H. Wu,^1,2 C-.J. Wen,^1,2 J-.J. Huang,^1,2,3 Y-.C. Pei,^1,2,3 C-.H. Lin,^1,2,4,5 H. Cheng,¹ Z-.L. Peng,^1,4,5 H-.I. Yang,⁶ F-.C. Wei.^1,2,5
The Predictive Power of MELD is Decreasing in the Era of Older, Sicker Patients

E. Godfrey,¹ J. Lai,² T. Miloh,³ N. Galvan,¹ R. Cotton,¹ C. O'Mahony,¹ J. Vierling,¹ N. Sussman,¹ A. Rana.¹
The Price of Diabetes Medication Management in Kidney Transplantation: Similar Rates of Readmissions, but More Healthcare Utilization

J. Hardcopf, H. Meadows, N. Pilch, C. Perez, N. Patel, J. Fleming, H. Corbo, T. Harrison, B. O'Brien, D. DuBay, D. Taber.
The Prognostic Implications of Renal Function Recovery and Delayed Graft Function in Kidney Transplantation

S. Sandal, M. Cantarovich, A. Ramankumar, N. Saberi, C. Saw, D. Baran, P. Chaudhury, S. Paraskevas, J. Tchervenkov.
The Promising Approach in Difficult Atypical Hemolytic Uremic Syndrome Series in Renal Transplantation

B. Yelken,¹ S. Gorcin,¹ E. Demir,² C. Karatas,³ E. Arpali,⁴ B. Akyollu,³ B. Kocak,⁴ O. Elbasi,⁵ E. Eksioğlu,⁵ A. Turkmen.²
The Protective Effect of Multivisceral Transplantation on Intestinal Allograft Rejection – Its Correlation with T-Cell Macrochimerism from a Long-Term Prospective Study

P. Liou,¹ M. Martinez,¹ J. Fu,² M. Velasco,¹ A. Griesemer,¹ S. Lobritto,¹ J. Vittorio,¹ S. Ravella,¹ B. Levin,³ J. Emond,¹ M. Sykes,² T. Kato.¹
The Providers Can't Let Go! An Analysis of an RN Driven Tacrolimus Dose Adjustment Protocol

Z. Elmaasarani, C. Mardis, L. Gylten, J. Fleming, H. Meadows, N. Patel, C. Perez, D. Taber, V. Rao, V. Rohan, P. Baliga, D. Dubay, N. Pilch.
The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients

A. Khalil,¹ A. Chhabra,¹ A. Merchak,¹ L. Kahn,¹ J. Leventhal,² S. Ildstad.¹
The Regulatory Role of Plasma Cells (as Bregs) is Counterbalanced by a NOVEL Inflammatory Role in Murine Transplant and Autoimmune Models

Z. Song,^1,2 Y. Zhou,² Q. Ding,¹ D. Rothstein.¹
The Relative Immunogenicity of HLA Mismatches in Adult Liver Transplant Recipients

V. Jucaud,¹ A. Shaked,² M. DesMarais,³ P. Sayre,³ M. Everly.¹
The Renal Sparing Protocol after Heart Transplant That Keeps Giving

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, R. Sharoff, J. Kobashigawa.
The Results of Plasmapheresis and Anti-CD20 Based Desensitization without Intravenous Immunoglobulin in Positive Crossmatch Kidney Transplants

H. Kwon, Y. KIm, J. Choi, S. Shin, J. Jung, M. Cho, J. Kim, D. Han.
The Results of the PRISM (Prediction of Rejection In Sensitized Patient Blood SaMples) Trial with a Novel Bioassay

F. Vincenti, A. Schroeder, S.-C. Hseish, J. Liberto, P. Towfighi, C. Koh, T. Sigdel, M. Sarwal.
The Risk Factors of Acute Rejection in Patients with BK Nephropathy after the Reduction of Immunosuppression

C. Baek,¹ H. Kim,¹ W. Yang,¹ D. Han,² S-.K. Park.¹
The Role of CD46 in Early Islet Engraftment in a Dual Transplant Model

Q. Gao, K. Samy, R. Davis, M. Song, A. MacDonald, F. Leopardi, T. How, K. Williams, G. Devi, B. Collins, A. Kirk.
The Role of Donor-Derived Cell-Free DNA in Identification of Injury in Kidney Allografts with Antibody-Mediated Rejection and De Novo DSA

H. Zhang,¹ L. Liu,¹ C. Zheng,² X. Li,¹ Q. Fu,¹ J. Li,¹ Q. Su,¹ H. Huang,¹ M. Ye,² C. Wang.¹
The Role of Ex Vivo Normothermic Preservation in Minimizing Postreperfusion Syndrome in Liver Transplantation

A. Hassan, J. Cywinski, Q. Liu, D. Pezzati, D. Yang, L. Liu, G. Iuppa, K. Hashimoto, F. Aucejo, M. Fujiki, B. Eghtesad, S. Irefin, J. Fung, K. Abu-Elmagd, C. Miller, C. Quintini.
The Role of NKT Cell /IL-17 Axis in the Autoimmune Lupus Nephritis

J. An,¹ Y. Kim,² M. Yu,² J. Lee,¹ C. Lee,³ Y. Kim,² S. Yang.⁴
The Role of pDCs in Formation of Treg-Rich Organized Lymphoid Structures in Spontaneously Accepted Murine Kidney Allografts is Dependent on Mismatching of MHC Class II Molecules at the H2-I-A^b Locus

T. O'Shea,^1,2 C. Yang,¹ I. Rosales,² N. Oh,¹ D. Ndishibandi,^1,2 T. Ashry,¹ P. Russell,¹ J. Madsen,¹ R. Colvin,² A. Alessandrini.^1,2
The Role of Pre-Emptive Antibiotic Therapy in Kidney Recipients of Donors with Urine-Only Positive Cultures

P. Cabrera,¹ A. Centeno,¹ J. Revollo,¹ J. Camargo.²
The Role of Resilience in Healthcare Transitions among Adolescent and Young Adult Kidney Transplant Recipients

S. Quinn,¹ H. Fernandez,² T. McCorkle,¹ F. Barg,³ K. Ginsburg, R. Rogers,¹ S. Amaral.
The Safety and Efficacy of Splenic Artery Ligation in Living Donor Liver Transplant Recipients

Y. Gunay, S. Ganesh, M. Molinari, A. Tevar, C. Hughes, A. Humar.
The Secret is Selection of Muscular Dystrophy for Success after Heart Transplant

M. Kittleson, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Study of the Influence on hIAPP Deposition and Dysfunction in INS-1 Cell by Calcineurin Inhibitors

J. Zhang, W. Lv, C. Zhang, N. Sun, X. Li, Y. Shi, A. Jiao, J. Lin, Y. Lv.
The Stunning Rise in Organ Donors Deceased from Drug Overdose

N. Agrawal,¹ S. Rhazouani,¹ D. Reino,¹ D. McMichael,² C. McClenney,³ D. Sears,¹ K. Al Khalloufi,¹ S. Gebreselassie,¹ S. Ebaid,¹ M. Berho,⁴ X. Zervos,¹ C. Sheffield,¹ A. Tzakis.¹
The Superiority of Plasma Enriched Perfusate for Assessment of Donor Kidneys in an Ex-Vivo Normothermic Perfusion (EVNP) Setting

J. Palma, I. Palma, Y. Smolin, A. Perry, J. Sageshima, R. Perez.
The Technique of Ileobladder and Kidney Transplantation in Rats and Pigs

M. Haberal,¹ M. Kirnap,¹ D. Ersoz,¹ D. Bacanli,² Z. Ersoy,³ M. Bayzakov,¹ A. Torgay,³ H. Ozdemir.⁴
The THINKER Trial: Quality of Life Results at 6- and 12-Month Follow-Up among Hepatitis C-Negative Patients Who Received Kidney Transplants from Deceased Donors with Hepatitis C Infection

V. Potluri, D. Goldberg, A. Peter, B. Emily, B. Roy, S. Deirdre, M. Levine, J. Trofe-Clark, M. Bleicher, S. Goral, A. Sicilia, S. Nazarian, R. Reddy, P. Porrett, P. Reese.
The TRANSFORM Study: Infection Outcomes with Everolimus Plus Reduced Calcineurin Inhibitor and Mycophenolate Plus Standard Calcineurin Inhibitor Regimens in De Novo Kidney Transplant Recipients

F. Vincenti, J. Cruzado, S. Mulgaonkar, V. Garcia, D. Kuypers, M. Buchler, F. Citterio, U. Huynh-Do, W-.L. Luo, P. Bernhardt, C. Sommerer.
The Transplant-Death Index: A Novel Method to Identify Disenfranchised Liver Transplant Waitlist Candidates

M. Kueht, J. Goss, N. Galvan, A. Rana.
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis

S. Wan,^1,2 T. Ying,^1,2 K. Wyburn,^1,2 D. Roberts,^3,4 M. Wyld,^1,2 S. Chadban.^1,2
The Use of LiMAx for Evaluating Donor Livers on Normothermic Machine Perfusion

J. Schurink,¹ J. de Haan,² M. Verstegen,¹ H. Metselaar,³ J. Ijzermans,¹ J. de Jonge.¹
The Utility and Futility of Extra-Corporeal Membrane Oxygenation in Liver Transplant Recipients

B. Nguyen, K. Dhanireddy, Y. Genyk, N. Kaur.
The Utility of a CD31/CD68 Dual Immunohistochemical Stain to Improve Accurate Diagnosis of Antibody Mediated Rejection in Cardiac Transplantation

C. Glass, Y. Butt, T. Gokaslan, J. Torrealba.
The Utility of an Online Survival Calculator in Selecting Older Candidates for Kidney Transplantation

M. Shwetar, K. Abdel-Kader, B. Concepcion.
The Value of Serum Dilution on DSA Outcome Analysis in Renal Transplantation

W. Huang,¹ L. Rebellato,² K. Briley,² P. Bolin,² S. Kendrick,³ A. Maldonado,⁴ D. Leeser,² C. Haisch,² M. Everly.¹
Therapeutic Drug Monitoring (TDM) of Suspension (SUS), Extended-Release (ER), and Intravenous (IV) Posaconazole (POS) at a Large Transplant Center

G. Haidar, R. Shields, C. Clancy, M. Nguyen.
Thirty-Six Consecutive Kidney Transplants in Recipients with Atypical Hemolytic Uremic Syndrome: A Single-Centre Experience

E. Favi,¹ G. Ardissino,² D. Cresseri,³ J. Brocca,¹ S. Testa,⁴ F. Tel,⁴ A. Giussani,¹ C. Colico,¹ C. Beretta,¹ M. Ferraresso.¹
Three-Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas-Kidney Transplantation in Type 2 Diabetes

T. Alhamad,¹ R. Kunjal,¹ A. Malone,¹ D. Brennan,² A. Wiseman,³ J. Wellen,¹ V. Hicks,¹ K. Lentine.⁴
Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors

K. Dessaix,¹ C. Bontoux,² O. Aubert,¹ J. Zuber,¹ R. Sberro Soussan,¹ V. Frémeaux-Bacchi,³ M. Le Quintrec,⁴ C. Legendre,¹ M. Rabant.²
Thymic Irradiation as a Maneuver for Repertoire Exchange in Costimulatory-Blockade-Based Immunotherapy

M. Mulvihill,¹ B. Ezekian,¹ Q. Gao,¹ K. Samy,¹ R. Davis,¹ F. Leopardi,¹ W. Giles,² F-.F. Yin,² C. Willett,² B. Collins,¹ A. Kirk.¹
Thymoglobulin Dose and Effect on Short-Term Kidney Transplant Outcomes

P. Sood, W. Christine, R. Mehta, A. Tevar, C. Puttarajappa, K. Schonder, K. Shimko, S. Hariharan.
Thymoglobulin Induction Decreases Risk of Death in HLA-Sensitized Kidney Recipients

C. Loheac, O. Aubert, M. Assayag, D. Viglietti, C. Lefaucheur, A. Loupy.
Thymoglobulin Induction in HIV Positive Kidney Transplant Recipients: Report on Transplant and HIV Outcomes

E. Gibney, T. Ommert, R. Cross, A. Ray, J. Lizcano.
Thymus Co-Transplantation Promotes Donor-Specific Tolerance in Allogeneic Heart Transplantation

J. Kwun,¹ J. Li,² C. Rouse,³ J. Park,¹ A. Kirk,¹ L. Markert.²
Time and Perfusate Dependent Molecular Response in Ex Vivo Lung Perfusion

P. Dromparis,¹ N. Aboelnazar,² S. Wagner,¹ S. Himmat,² C. White,² J. Luc,² D. Freed,² J. Nagendran,² M. Mengel,¹ B. Adam.¹
Time in Therapeutic Range Predicts DSA Development and Acute Rejection in Kidney Recipients with High Tacrolimus Coefficient of Variation

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.
Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations in Renal Transplant Recipients

K. Khalil, P. West-Thielke, A. Lichvar, E. Benedetti, S. Patel.
Time-Effect of Donor and Recipient Characteristics on Graft Survival after Kidney Transplantation

E. Molmenti,¹ J. Yang,³ C. Molmenti,² E. Grodstein,¹ H. Rilo,¹ L. Teperman.¹
Timeline and Histopathological Characteristics of Graft Failure after Kidney Transplantation: What is Preventable and What is Not?

S. Parajuli, F. Aziz, N. Garg, B. Muth, M. Mohamed, W. Zhong, B. Astor, D. Mandelbrot, A. Djamali.
Timing of Infections after Total Artificial Heart Implantation. What Did We Learn?

H. Chambers, A. Kalil, D. Florescu.
Timing of Treatment for Chronic Hepatitis C Infection in Patients with End-Stage Renal Disease Awaiting Transplantation

M. Eckman,¹ E. Woodle,² C. Thakar,¹ F. Paterno,² K. Sherman.¹
Tipping the “Immune Balance” towards Tolerance by Specific and Systematic Depletion of Donor and Host Effector Cells

R. Bascom, K. Tao, L. West.
Tissue Talks: Graft´s Histological Findings 10 Years after Belatacept or CNI

G. Mondragon-Ramirez,¹ N. Uribe-Uribe,² J. Arreola-Guerra,⁵ R. Reyes-Acevedo,⁵ M. Vilatoba,³ J. Furuzawa-Carballeda,⁴ A. Lopez-Toledo,¹ G. Mondragon-Salgado,¹ J. Alberu.³
Title: Donor-Derived Cell Free DNA Predicts Development of Clinically Significant Changes in Donor Specific Antibody Following Kidney Transplant

A. Brubaker,¹ D. Stoltz,¹ M. Grskovic,² R. Woodward,² A. Gallo.¹
TLR-Activated Bregs Promote Islet Allograft Tolerance in an IL-10-Independent and TGF-β-Dependent Manner

L. Kojima, K. Lee, K. Deng, H. Tector, C. Dai, S. Kimura, C. Rickert, H. Yeh, J. Markmann.
TLR2 with TCR Signaling Mobilizes Treg Lymphatic Migration

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
To Score a Pancreas, Stars Must Be Aligned

A. Friedman, P. Bagavan, K. Delli Carpini.
Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR)

S. Patel, S. Mohan, H. Fernandez, I. Batal, L. Ratner, J. Crew.
Tomotherapy and Donor Hematopoietic Cells for Tolerance to Kidney Transplants in Rhesus Macaques

D. Kaufman,¹ L. Haynes,¹ P. Hematti,¹ W. Burlingham,¹ L. Forest,² J. Post,¹ R. Redfield,¹ L. Fernandez,¹ A. D'Alessandro,¹ J. Haynes,¹ K. Jensen,³ S. Strober.³
TORC1 Inhibition Protects Activated Human Regulatory T Cells from Self-Inflicted Damage via Granzyme B

B. Al Dulaijan, S. Eskandari, J. Karnyski, J. Assaker, S. Cai, A. Mansouri, M. Mohamed, J. Azzi.
Torsion and Inversion of Intraperitoneal Kidneys Manifesting as Acute Allograft Dysfunction – A Case Series

P. Kandula, A. Patel, S. Bains, H. Sun.
TP53 Mutations Lead to Increased Transcription of Circular RNAs in Exosomes Enhancing Tumor Invasiveness in Hepatocellular Carcinoma Bases on Bioinformatics Analysis

Z. Yu, Y. Hou, R. Wang, X. Huang.
Transmission of Rabies through Solid Organ Transplant: A Big Issue in China

J. Zhang, J. Lin, Y. Tian, L. Ma, W. Sun, L. Zhang, Y. Zhu, W. Qiu, L. Zhang.
Transplant Benefit to Patients with Long Dialysis Vintage

A. Massie, D. Crews, T. Purnell, J. Garonzik-Wang, D. Segev.
Transplant Candidates and Potential Living Kidney Donors Are Supportive of Reciprocity for Transplant Candidates Who Participate in Kidney Paired Donation with a Compatible Donor

J. Gill,¹ J. Gill,¹ F. Ballesteros,² M. Fortin.²
Transplant Community Perceptions of the Benefits and Drawbacks of Alternative Quality Metrics for Regulation

S. Rasmussen, S. Zhou, A. Thomas, D. Segev, L. Hersch Nicholas.
Transplant Cost Reduction in a Developing Country: “The Case of Guatemala”

S. Méndez,¹ B. Remey,² E. Reyes,¹ A. Aguilar-González,¹ R. Lou-Meda.¹
Transplant Hepatectomy with Portacaval Shunt and Molecular Adsorbent Recirculating System (MARS) Therapy for Perioperative Catastrophe

A. Cimeno, S. Sultan, J. Alvarez-Casas, S. Hanish, D. Bruno, W. Hutson, D. Stein, T. Scalea, R. Barth, J. LaMattina.
Transplant Hospitals Increase Volumes and Acceptance Rates under the COIIN Project

D. Klassen, H. Haskell, K. Sisaithong, M. McBride, R. Carrico, M. Curry.
Transplant Outcomes in Female African American Recipients

A. Patel,¹ R. Prashar,¹ D. Lim.²
Transplant Psychiatry- A Growing Subspecialty. Introducing the Transplant Psychiatry Special Interest Group from the Academy of Psychosomatic Medicine

P. Zimbrean,¹ A. DiMartini,² C. Crone.³
Transplant Surgeon Perspectives on General Surgery in Transplant Recipients

S. DiBrito, M. Bowring, S. Rasmussen, C. Haugen, C. Holscher, N. Zonnenberg, M. Henderson, D. Segev, J. Garonzik-Wang.
Transplant Tourism and Invasive Fungal Infection

F. Al Ismaili,¹ A. Metry,³ M. Al Riyami,⁵ F. Khamis,⁶ F. Shaheen,⁷ A. Hola,⁴ I. Al Salmi.²
Transplant Trends in Young Adults: Silent Alcohol Epidemic

N. Kemmer,² N. Bozanich,¹ S. Agrawal,² C. Albers,² R. Syed,² A. Alsina.²
Transplantation of DCD Livers vs. NDD and LDLT: Is There a Difference in Post-Transplant Kidney Dysfunction?

D. Kollmann,¹ S. Neong,¹ R. Rosales,¹ G. Sapisochin,¹ M. Bhat,¹ M. Cattral,¹ P. Greig,¹ L. Lilly,¹ D. McGilvray,¹ A. Ghanekar,¹ D. Grant,¹ M. Selzner,¹ F. Wong,² N. Selzner.¹
Transplantation of Kidneys from Hepatitis C Virus (HCV) Antibody (Ab) Positive, NAT Negative Donors to HCV Negative Patients Results in Seroconversion but Not Viral Transmission

M. de Vera, M. Volk, Z. Ncube, A. Kore, M. Robinson, P. Wai, S. Blais, P. Baron, R. Villicana.
Transplantation of Restored Kidneys from Living Related Donors after Small Renal Tumor Resection: Report of 5 Cases

Y. Ogawa,¹ S. Shiroma,² K. Kojima,² R. Mannami,² M. Mannami,² N. Mitsuhata,² M. Nishi,⁴ H. Afuso.³
Transplantation of Very Small Pediatric En Bloc Renal Allografts from Donors Less Than 8 Months of Age Have Similar Outcomes to Donors More Than 8 Months

S. Aquil,^1,2,3 N. Mitrou,^1,3 V. McAlister,^1,2,3 A. Sener,^1,2,3 P. Luke.^1,2,3
Transplantation Tolerance Prevents CMV Reactivation and Preserves Kidney Allograft Function in a D+/R- Transplant Setting

A. Dangi,¹ J-.J. Wang,² M. Burnette,¹ Z. Zhang,² X. Luo.^1,2
Transplantation Tourism and Recipients Perspectives and Experience

F. Al Rahbi, I. Al Salmi.
Transplanting Kidneys from HCV-Infected Donors into HCV-Negative Recipients: Longer-Term and Extended Results of the THINKER Trial

D. Goldberg,¹ E. Blumberg,¹ P. Abt,¹ M. Levine,¹ P. Porrett,¹ A. Naji,¹ S. Nazarian,¹ D. Sawinski,¹ J. Trofe-Clark,¹ V. Van Deerlin,¹ C. Gentile,¹ J. Smith,¹ M. Kaminski,¹ A. Sicilia,¹ R. Hasz,² L. Suplee,² R. Reddy,¹ R. Bloom,¹ P. Reese.¹
Treatment and Outcomes of Orthotopic Liver Transplant Patients Secondary to Hepatitis C Virus: A Single Center Experience

T. Chen,¹ M. Moaddab,¹ B. Pierce,¹ R. Ghobrial.²
Treatment of Active Chronic Antibody-Mediated Rejection with Rituximab, IVIG and Plasma Exchange

G. Piñeiro,¹ J. Rovira,² E. De Sousa-Amorim,¹ J. Villarreal,¹ M. Sole,³ I. Revuelta,¹ M. Lozano,⁴ E. Palou,⁴ F. Oppenheimer,¹ J. Campistol,¹ F. Diekmann.^1,2
Treatment of BK Viremia: Single-Center Experience

A. Karim, A. Hines, K. Wang, S. Saleh, B. Suleiman, W. Hassan, A. Maibam, M. Yaseen, A. Castellanos, V. Cornea, X. Mei, R. Gedaly, T. Waid, A. El-Husseini.
Treatment of HCV Infection in Renal Transplant Recipients

M. Rial, L. Tana, C. Alonso, H. Curcio, E. Chulluyan, D. Casadei.
Treatment of Multi-Drug Resistant Gram Negative Infections after Solid Organ Transplant

M. Heldman, B. Nelson, T. Babu, M. Ison.
Treatment of Post Transplant Hepatitis C (HCV) with Direct-Acting Antiviral (DAA) Agents May Improve Liver Function but Does Not Lead to an Increase in Liver Rejection

P. Sheiner, N. Mello, G. Baixauli, M. Einstein, C. Rochon, Y. Kwon, M. Bejon.
Treatment Outcomes of FSGS Recurrence

J. Mansur,¹ D. Chang,² G. Medeiros,¹ M. Cristelli,¹ L. Viana,¹ S. Stopa,¹ C. Felipe,¹ G. Kirsztajn,¹ H. Tedesco-Silva.¹
Treatment Outcomes of Recurrent Primary Focal Segmental Glomerulosclerosis (FSGS) after Kidney Transplantation

R. Aguiar,¹ F. Pereira,² A. Gasparini,³ P. Chowdhury,¹ D. Game,¹ D. Moutzouris.¹
Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis

X. Huang,² N. Joshi,¹ L. Luo,¹ G. Mitri,³ B. Lovelace,² A. Pham,³ X. Gao.¹
Treg Regulate Distinct Lymphatic NFκB Signaling Pathways to Alter Migration and Immunity

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
Tregs Expression Predicts Prognosis in Patients with Hepatocellular Carcinoma

A. Baquerizo,¹ V. Vavinskaya,² C. Frenette,¹ M. Nelson,¹ R. Schaffer,¹ J. Fisher,¹ L. Sher,³ B. Madani,¹ P. Pockros,¹ C. Marsh.¹
Trends and Policy Influences on Multiple Listing Practices for Kidney Transplantation between 2000 and 2017

M. Decoteau,¹ D. Stewart,² A. Toll,² J. Case,¹ C. Marsh.¹
Trends in Liver Transplantation with Older Liver Donors in the United States

C. Haugen, X. Luo, A. Thomas, C. Holscher, J. Garonzik-Wang, M. McAdams-DeMarco, D. Segev.
Trends in Safety Reporting to UNOS by Event Type

A. Doyle,¹ S. Tlusty,² R. Urban,² M. Marvin,³ E. Hollinger,⁵ D. Marshman,⁴ M. Green.⁵
Trends in Safety Reporting to UNOS Related to Non-Recovery, Discard, or Delay

A. Doyle,¹ R. Urban,² S. Tlusty,² M. Marvin,³ E. Hollinger,⁴ D. Marshman,⁵ M. Green.⁶
Trends of Racial and Education Disparity in Post-Kidney-Transplant Graft Survival and Patient Survival: Do Different Metrics Lead to Different Conclusions?

M. Garber, K. Ross, R. Hamoda, L. Plantinga, R. Patzer.
Trends, Patterns, and Recipient Outcomes of Kidney Transplants from Older (>60) Living Donors. A UNOS Database Analysis

A. Riaz, O. Adebiyi, M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin.
Triptolide Reduces the Required Dose of Tacrolimus by Attenuating Inflammation, Enhancing Immunosuppression, and Increasing Donor Chimerism in a Heterotopic Hindlimb Transplantation Model

C. Gu, F. Liu, J. Yang.
Tuberculosis among Kidney Transplant Patients Compared to Dialysis and Non-Dialysis CKD Patients over a Decade Period

A. Metry, I. Al Salmi, F. Al Ismaili, A. Hola, F. Shaheen, I. Al Salmi.
Tumor Recurrence in Kidney Transplant Recipients with a History of Pretransplant Malignancy

F. Becker,¹ K. Schütte Nütgen,² S. Reuter,² L. Kebschull,¹ T. Vowinkel,¹ N. Senninger,¹ D. Palmes,¹ T. Vogel,¹ R. Bahde.¹
Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life after Kidney Transplantation

T. Schachtner,^1,2,3 N. Otto,¹ P. Reinke.^1,2
Two Similar Risk Models Identify Different Patients for Graft Loss: Implications for Clinical Trials in DSA+ Kidney Transplant Recipients

A. Bentall, B. Smith, W. Park, C. Schinstock, M. Stegall.
Two Trajectories of Post-DSA eGFR after Kidney Transplant

J. Beaumont,¹ K. Briley,² A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² L. Rebellato,² M. Everly.¹
Two Years of the HOPE Act

A. Wilk,¹ C. Durand,² D. Segev,² D. Klassen.¹
Type I NKT Cells Augment Humoral and Cellular Alloimmunity in Response to Hepatocyte Transplantation

S. Elzein, J. Zimmerer, B. Ringwald, C. Avila, G. Bumgardner.
Type-1 Interferon Impairs the Immunoregulatory Activity of IL-10: Understanding the Mechanisms of Abrogation of Transplant Tolerance

M. Iglesias, A. Arun, M. Chicco, B. Lam, V. Ivanova, W. Lee, G. Brandacher, G. Raimondi.